ENT Studios Meta: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ENT Studios Meta
Largest movements
- Receivables within one year -€61,409
down €61,409 (-80.9%), from €75,891 to €14,482
of which Trade receivables: -€61,105
- Cash +€7,302
up €7,302 (+117%), from €6,219 to €13,521
mainly Receivables within one year (+€61,409) and Depreciation (+€38)
- Profit (loss) carried forward -€25,804
down €25,804 (-44.5%), from -€57,924 to -€83,728
- Other debts -€23,811
down €23,811 (-25.9%), from €91,929 to €68,118
- Accrued charges and deferred income -€3,127
no longer reported in 2025 (was €3,127)
- Gross operating margin +€4,695
up €4,695 (+15.9%), from -€29,579 to -€24,885
- Financial charges -€3,098
down €3,098 (-91.9%), from €3,369 to €271
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €83,229 | €29,707 | -€53,522 | -64.3% |
| Fixed assets | 21/28 | €2 | €588 | +€586 | +29,290% |
| Tangible fixed assets | 22/27 | - | €586 | +€586 | |
| Plant, machinery and equipment | 23 | - | €586 | +€586 | |
| Financial fixed assets | 28 | €2 | €2 | = | 0.0% |
| Current assets | 29/58 | €83,227 | €29,119 | -€54,107 | -65.0% |
| Amounts receivable within one year | 40/41 | €75,891 | €14,482 | -€61,409 | -80.9% |
| Trade receivables | 40 | €75,135 | €14,030 | -€61,105 | -81.3% |
| Other amounts receivable | 41 | €756 | €452 | -€304 | -40.3% |
| Cash at bank and in hand | 54/58 | €6,219 | €13,521 | +€7,302 | +117% |
| Deferred charges and accrued income | 490/1 | €1,117 | €1,117 | -€0 | 0.0% |
| Total equity and liabilities | 10/49 | €83,229 | €29,707 | -€53,522 | -64.3% |
| Equity | 10/15 | -€12,624 | -€38,428 | -€25,804 | -204% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Reserves | 13 | €43,300 | €43,300 | = | 0.0% |
| Distributable reserves | 133 | €43,300 | €43,300 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€57,924 | -€83,728 | -€25,804 | -44.5% |
| Amounts payable | 17/49 | €95,853 | €68,135 | -€27,718 | -28.9% |
| Amounts payable within one year | 42/48 | €92,726 | €68,135 | -€24,591 | -26.5% |
| Trade debts | 44 | €29 | €17 | -€12 | -41.4% |
| Suppliers | 440/4 | €29 | €17 | -€12 | -41.4% |
| Taxes, remuneration and social security | 45 | €768 | - | -€768 | |
| Taxes | 450/3 | €768 | - | -€768 | |
| Other amounts payable | 47/48 | €91,929 | €68,118 | -€23,811 | -25.9% |
| Accrued charges and deferred income | 492/3 | €3,127 | - | -€3,127 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €40 | €38 | -€2 | -5.5% |
| Other operating charges | 640/8 | €592 | €610 | +€18 | +3.0% |
| Gross operating margin | 9900 | -€29,579 | -€24,885 | +€4,695 | +15.9% |
| Operating profit (loss) | 9901 | -€30,211 | -€25,532 | +€4,679 | +15.5% |
| Financial charges | 65/66B | €3,369 | €271 | -€3,098 | -91.9% |
| Recurring financial charges | 65 | €3,369 | €271 | -€3,098 | -91.9% |
| Profit (loss) for the period before taxes | 9903 | -€33,581 | -€25,804 | +€7,777 | +23.2% |
| Profit (loss) for the period | 9904 | -€33,581 | -€25,804 | +€7,777 | +23.2% |
| Profit (loss) for the period to be appropriated | 9905 | -€33,581 | -€25,804 | +€7,777 | +23.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.